Gregory Scott Duncan - Net Worth and Insider Trading
Gregory Scott Duncan Net Worth
The estimated net worth of Gregory Scott Duncan is at least $12,032 dollars as of 2024-05-26. Gregory Scott Duncan is the CHIEF EXECUTIVE OFFICER of Virios Therapeutics Inc and owns about 57,461 shares of Virios Therapeutics Inc (VIRI) stock worth over $12,032. Details can be seen in Gregory Scott Duncan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gregory Scott Duncan has not made any transactions after 2023-08-17 and currently still holds the listed stock(s).
Transaction Summary of Gregory Scott Duncan
Gregory Scott Duncan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gregory Scott Duncan owns 2 companies in total, including Cormedix Inc (CRMD) , and Virios Therapeutics Inc (VIRI) .
Click here to see the complete history of Gregory Scott Duncan’s form 4 insider trades.
Insider Ownership Summary of Gregory Scott Duncan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRMD | Cormedix Inc | 2020-11-02 | director |
| VIRI | Virios Therapeutics Inc | 2023-08-17 | director & Chief Executive Officer |
Gregory Scott Duncan Latest Holdings Summary
Gregory Scott Duncan currently owns a total of 1 stock. Gregory Scott Duncan owns 57,461 shares of Virios Therapeutics Inc (VIRI) as of August 17, 2023, with a value of $12,032.
Latest Holdings of Gregory Scott Duncan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VIRI | Virios Therapeutics Inc | 2023-08-17 | 57,461 | 0.21 | 12,032 |
Holding Weightings of Gregory Scott Duncan
Gregory Scott Duncan Form 4 Trading Tracker
According to the SEC Form 4 filings, Gregory Scott Duncan has made a total of 5 transactions in Virios Therapeutics Inc (VIRI) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Virios Therapeutics Inc is the acquisition of 25,000 shares on August 17, 2023, which cost Gregory Scott Duncan around $31,250.
Insider Trading History of Gregory Scott Duncan
- 1
Gregory Scott Duncan Trading Performance
GuruFocus tracks the stock performance after each of Gregory Scott Duncan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory Scott Duncan is 1.53%. GuruFocus also compares Gregory Scott Duncan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory Scott Duncan within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gregory Scott Duncan's insider trading performs compared to the benchmark.
Performance of Gregory Scott Duncan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.44 | | | | | |
| Relative Return to S&P 500(%) | -8.9 | | | | | |
Gregory Scott Duncan Ownership Network
Gregory Scott Duncan Owned Company Details
What does Cormedix Inc do?
Who are the key executives at Cormedix Inc?
Gregory Scott Duncan is the director of Cormedix Inc. Other key executives at Cormedix Inc include director & Chief Executive Officer Joseph Todisco , Chief Commercial Officer Erin Mistry , and EVP & Chief Financial Officer Matthew T David .
Cormedix Inc (CRMD) Insider Trades Summary
Over the past 18 months, Gregory Scott Duncan made no insider transaction in Cormedix Inc (CRMD). Other recent insider transactions involving Cormedix Inc (CRMD) include a net purchase of 28,561 shares made by Joseph Todisco , a net purchase of 9,000 shares made by Alan W Dunton , and a net purchase of 10,000 shares made by Paulo F Costa .
In summary, during the past 3 months, insiders sold 0 shares of Cormedix Inc (CRMD) in total and bought 13,561 shares, with a net purchase of 13,561 shares. During the past 18 months, 0 shares of Cormedix Inc (CRMD) were sold and 64,561 shares were bought by its insiders, resulting in a net purchase of 64,561 shares.
Cormedix Inc (CRMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cormedix Inc Insider Transactions
Gregory Scott Duncan Mailing Address
Above is the net worth, insider trading, and ownership report for Gregory Scott Duncan. You might contact Gregory Scott Duncan via mailing address: 44 Milton Avenue, Alpharetta Ga 30009.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
